[Excretion of catecholamines and DOPA in lipid metabolism disorders].
Excretion of catecholamines and DOPA was impaired in patients with metabolic-alimentary obesity, with ischemic disease of heart, with atherosclerosis and excessive weight. Distinct decrease in content of adrenaline, noradrenaline and DOPA was observed in patients with obesity; the phenomenon was less pronounced in ischemic disease of heart, mainly in aged patients. Correlation was found between the rate of excretion of catecholamines and DOPA and the extent of hyperlipidemia. Dietetics did not normalize completely the impairments studied. Additional administration of pyridoxine caused a favorable effect.
D000293:Adolescent; D000328:Adult; D000375:Aging; D001835:Body Weight; D003327:Coronary Disease / Q000652:urine*; D004035:Diet Therapy; D004295:Dihydroxyphenylalanine / Q000652:urine*; D004837:Epinephrine / Q000652:urine*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine*; D009765:Obesity / Q000628:therapy / Q000652:urine*; D011736:Pyridoxine / Q000627:therapeutic use
D004295:Dihydroxyphenylalanine; D011736:Pyridoxine; D009638:Norepinephrine; D004837:Epinephrine
Ekskretsiia katekholaminov i DOFA pri narusheniiakh metabolizma lipidov.